Direct-Acting Oral Anticoagulants: A Resident-Based Workshop to Improve Knowledge and Confidence

Introduction Direct-acting oral anticoagulant (DOAC) prescriptions have increased steadily since the first, dabigatran, was Food and Drug Administration-approved in 2010. They have multiple advantages over vitamin K antagonists including fixed dosing without coagulation lab monitoring, rapid onset a...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Irsk Anderson, Vineet M. Arora
Format: article
Langue:EN
Publié: Association of American Medical Colleges 2020
Sujets:
L
Accès en ligne:https://doaj.org/article/511b1d672fe740d8ae9695db81278f28
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!